microbiology an evolving science test bank

Correct Answer: D

Rationale: The correct answer is D: all of them. Malignant disease weakens the immune system, making individuals more susceptible to infections. Cytostatic therapy suppresses the immune system, increasing the risk of infections. Premature birth can lead to underdeveloped immune systems, making babies more prone to infections. Therefore, all three choices are risk factors for the development of infections. Other choices are incorrect because each individual risk factor listed contributes to an increased susceptibility to infections.

Correct Answer: A

Rationale: The correct answer is A: Nystatin. Nystatin is specifically used to treat intestinal candidiasis because it targets and eliminates the Candida species responsible for the infection. It is not absorbed systemically, acting only locally in the gastrointestinal tract. Griseofulvin (B) is mainly used to treat fungal skin infections, not intestinal candidiasis. Undecyne (C) is an antifungal agent used for skin infections, not for intestinal candidiasis. Amphotericin B (D) is a potent antifungal agent used for systemic fungal infections, not specifically for intestinal candidiasis.

Correct Answer: B

Rationale: The correct answer is B because in immune reactions, a large lattice is formed when antigens and antibodies are in optimal proportion. This optimal ratio allows for the formation of a strong antigen-antibody complex, leading to the aggregation of immune complexes into large lattice structures. When antibodies are in excess (choice A), there may not be enough antigens to form a stable lattice. Similarly, when antigens are in excess (choice C), there may be insufficient antibodies to form a strong lattice. Choice D is incorrect because the optimal proportion of antigens and antibodies is crucial for the formation of large lattices in immune reactions.

Correct Answer: D

Rationale: The correct answer is D: Relenza and Tamiflu. Both Relenza and Tamiflu are anti-influenza drugs that target the neuraminidase enzyme of the influenza virus, thereby inhibiting its replication and spread. Maxi Grip (A) is not an anti-influenza drug, Theraflu (B) contains different active ingredients, and Amantadine and Rimantadine (C) target a different viral protein, M2 ion channel. Therefore, choices A, B, and C are incorrect as they do not specifically target neuraminidase for influenza treatment.

Correct Answer: D

Rationale: The correct answer is D: nonproprietary. The generic name of a drug is the official, nonproprietary name given to a drug by an organization such as the U.S. Food and Drug Administration (FDA). This name is not owned by any specific company and is used universally to identify the drug's active ingredient. The generic name helps to communicate the specific medication being prescribed and allows for cost-effective options for consumers. A: Trade name refers to the brand name given to a drug by a pharmaceutical company. B: Proprietary name is another term for the trade name, specific to the company that produces the drug. C: Chemical name refers to the exact chemical composition of the drug, which may not be user-friendly or easily recognized by healthcare professionals or consumers.